Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shapira

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Pharmaceutical Research|August 1, 1988
Dynamics of bromodeoxyuridine incorporation into DNA of squamous carcinoma cells during mid and late logarithmic growthA Shapira, J G Wagner, I S Wollner, et al.
Journal of Gambling Studies|June 30, 2006
Is speeding a form of gambling in adolescents?David S Husted, Mark S Gold, Kimberly Frost-Pineda, et al.
Depression and Anxiety|June 24, 2003
Problematic internet use: proposed classification and diagnostic criteriaNathan A Shapira, Mary C Lessig, Toby D Goldsmith, et al.
Biological Psychiatry|March 17, 2004
A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorderNathan A Shapira, Herbert E Ward, Miguel Mandoki, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 3, 2006
Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programmingMichael S Okun, Giselle Mann, Kelly D Foote, et al.
Depression and Anxiety|July 15, 2006
Clinical predictors of early fluoxetine treatment response in obsessive-compulsive disorderEric A Storch, Michael J Larson, Nathan A Shapira, et al.
The American Journal of Psychiatry|February 4, 2003
Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trialSusan L McElroy, Lesley M Arnold, Nathan A Shapira, et al.
Journal of Viral Hepatitis|January 14, 2012
Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activityL Bachmetov, M Gal-Tanamy, A Shapira, et al.
Neurology|February 28, 2002
Three novel COLQ mutations and variation of phenotypic expressivity due to G240XY A Shapira, M E Sadeh, M P Bergtraum, et al.
Biological Psychiatry|September 27, 2003
Brain activation by disgust-inducing pictures in obsessive-compulsive disorderNathan A Shapira, Yijun Liu, Alex G He, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Pharmaceutical Research|August 1, 1988
Dynamics of bromodeoxyuridine incorporation into DNA of squamous carcinoma cells during mid and late logarithmic growthA Shapira, J G Wagner, I S Wollner, et al.
Journal of Gambling Studies|June 30, 2006
Is speeding a form of gambling in adolescents?David S Husted, Mark S Gold, Kimberly Frost-Pineda, et al.
Depression and Anxiety|June 24, 2003
Problematic internet use: proposed classification and diagnostic criteriaNathan A Shapira, Mary C Lessig, Toby D Goldsmith, et al.
Biological Psychiatry|March 17, 2004
A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorderNathan A Shapira, Herbert E Ward, Miguel Mandoki, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 3, 2006
Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programmingMichael S Okun, Giselle Mann, Kelly D Foote, et al.
Depression and Anxiety|July 15, 2006
Clinical predictors of early fluoxetine treatment response in obsessive-compulsive disorderEric A Storch, Michael J Larson, Nathan A Shapira, et al.
The American Journal of Psychiatry|February 4, 2003
Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trialSusan L McElroy, Lesley M Arnold, Nathan A Shapira, et al.
Journal of Viral Hepatitis|January 14, 2012
Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activityL Bachmetov, M Gal-Tanamy, A Shapira, et al.
Neurology|February 28, 2002
Three novel COLQ mutations and variation of phenotypic expressivity due to G240XY A Shapira, M E Sadeh, M P Bergtraum, et al.
Biological Psychiatry|September 27, 2003
Brain activation by disgust-inducing pictures in obsessive-compulsive disorderNathan A Shapira, Yijun Liu, Alex G He, et al.
Pageof 9